The impact of COVID-19 threats, and preventive chain of action: molecule to medicine

Authors

  • Mohammed H. Alqahtani Department of Public Health, School of Health Sciences and Practice, New York Medical College, Valhalla NY.
  • Diane E. Heck Department of Public Health, School of Health Sciences and Practice, New York Medical College, Valhalla NY.
  • Hong Duck Kim Department of Public Health, School of Health Sciences and Practice, New York Medical College, Valhalla NY.

DOI:

https://doi.org/10.30574/gscbps.2021.17.3.0232

Keywords:

SARS-CoV-2, COVID-19, mRNA vaccine, Detection of virus antigen, Neutralization antibody, Surveillance system, Molecular-based risk assessment skills, Omics

Abstract

The emergence of the novel coronavirus (SARS-CoV-2) had affected us significantly from the individual level, to nationwide and global with a big loss of finances, and the freezing of various factories, schools, and transportation in communities The pandemic started with anxiety and a loss of health guidance and policies due to the unknown causes of viral transmission to human features as well as a high infection rate with low mortality It remains the original source of Covid-19 where it comes from and what is the reality of real viral entities and its origin such as natural born and recombinant viral variants in the case of COVID-19 pandemic. This sentence is unclear. In this short perspective article, we address some issues of risk assessment and management issues using molecular-based decision tools which may benefit or provide future drills to counteract health and clinic safety against a viral pandemic. Every pandemic gives us life threatening lessons on previous and disconnected human networks due to uncertainty of viral infection, which we learned from this COVID-19 pandemic case as well. It gives us some insight on how to rebuild our community regarding the strength of public health and the integration of science tools into the early phase of medical application, such as the role of molecular diagnostics through educational engagement. To promote the value of awareness with solid knowledge-based communication and to develop resilient preventive solutions for supply chains or prevention, the systematic practice of connectivity through visual format using multidimensional data outcomes could help reconsider the leverage of molecules as a bridge for the improvement and application of updated scientific tools of prediction precisely to identify unknown pathogens encompass rigor community-based activity likelihood sensitivity and resistance to pathogen infiltrated society in the future.

Metrics

Metrics Loading ...

References

Abdulla Hama Salih M. An overview on the pandemic coronavirus disease 2019 (COVID-19) outbreak. Kurdistan Journal of Applied Research. 2020; 31-36.

Balanzá–Martínez V, Atienza–Carbonell B, Kapczinski F, De Boni RB. Lifestyle behaviours during the COVID‐19 – time to connect. Acta Psychiatrica Scandinavica. 2020; 141(5): 399-400.

Boness CL, Nelson M, Douaihy A. Motivational interviewing strategies for addressing COVID-19 vaccine hesitancy. 2021.

Boreskie K, Hay J, Duhamel T. Preventing frailty progression during the COVID-19 pandemic. Journal of Frailty & Aging. 2020; 1-2.

Centers for Disease Control and Prevention. Coronavirus disease 2019 (COVID-19). 2020.

Centers for Disease Control and Prevention. Coronavirus disease 2019 (COVID-19). Centers for Disease Control and Prevention. 2021.

Chu D, Duda S, Solo K, Yaacoub S, Schunemann H. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-Cov-2 and COVID-19: A systematic review and meta-analysis. Journal of Vascular Surgery. 2020; 72(4): 1500.

DiMaio D, Enquist LW, Dermody TS. A new coronavirus emerges, this time causing a pandemic. Annual Review of Virology. 2020; 7(1): iii-v.

Dinleyici EC, Borrow R, Safadi MA, Van Damme P, Munoz FM. Vaccines and routine immunization strategies during the COVID-19 pandemic. Human Vaccines & Immunotherapeutics. 2020; 17(2): 400-407.

Kirkcaldy RD, King BA, Brooks JT. COVID-19 and Postinfection immunity. JAMA. 2020; 323(22): 2245.

Liu Y, Kuo R, Shih S. COVID-19: The first documented coronavirus pandemic in history. Biomedical Journal. 2020; 43(4): 328-333.

Majumder M, Mandl KD. Early transmissibility assessment of a novel coronavirus in Wuhan, China. SSRN Electronic Journal. 2020.

Olliaro P. What does 95% COVID-19 vaccine efficacy really mean? The Lancet Infectious Diseases. 2021.

Oronsky B, Gruber HE, Reiners W, Reid TR. A short discussion about the SARS-Cov-2 mrna-1273 vaccine. International Journal of Infectious Diseases. 2021; 104: 532-533.

Velavan, Thirumalaisamy P, Meyer Christian G. The COVID‐19 epidemic. Trop Med Int Health. Mar 2020; 25(3): 278–280.

World Health Organization. The race for a COVID-19 vaccine. WHO | World Health Organization. 2020.

World Health Organization. Coronavirus update (Live): 13,953,344 cases and 592,778 deaths from COVID-19 virus pandemic. Worldometer - real time world statistics. 2021.

Wu YC, Ching-Sung C, Chen J, Chan Z, Yu-Jiun Y. The outbreak of COVID-19: An overview. Journal of the Chinese Medical Association. 2020; 83(2): 217-220.

Downloads

Published

2021-12-30

How to Cite

Alqahtani, M. H. ., Heck, D. E. ., & Kim, H. D. . (2021). The impact of COVID-19 threats, and preventive chain of action: molecule to medicine. GSC Biological and Pharmaceutical Sciences, 17(3), 119–123. https://doi.org/10.30574/gscbps.2021.17.3.0232

Issue

Section

Review Article